Delivery Order SPE2DB22D3019-SPE2DB24FK3NS
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,333.15 firm fixed price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG tablets, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,888.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG tablets, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of August 5, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $5,871.06 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is to provide the drug product JOLESSA 0.15 MG-0.03 MG TABLET 91S to DLA facilities. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,545.13 firm fixed-price delivery order contract is for the supply of JOLESSA TABS 3X 91S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a...
This federal contract award SPE2DB20D7059|SPE2DB24FQMP9 is a $5,926.47 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The award has a completion date of September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including the DLA, through its extensive federal contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a variety of medical products and supplies. The $2,180.13 Firm Fixed Price contract provides for the delivery of the medication Jolessa 0.15 mg-0.03 mg tablet through October 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.16, is for the delivery of JOLESSA 0.15 MG-0.03 MG tablets, a prescription medication. This award is not set aside for a specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S to the Defense Logistics Agency (DLA). The $1,222.96 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 4, 2024, with an ultimate completion date of October 7, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is associated with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has a ceiling value of $1,213.53 and an ultimate completion date of May 21, 2024. It is a firm fixed-price delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products...